id | C00001819 |
---|---|
Name | Thalsine / Majarine / Berberine / Umbellatin |
CAS RN | 2086-83-1 |
Standard InChI | InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1 |
Standard InChI (Main Layer) | InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 155 |
By standard InChI | CHEMBL295124 |
---|---|
By standard InChI Main Layer | CHEMBL295124 |
By LinkDB | C00757 |
---|
By CAS RN | D001599 |
---|
class name | count |
---|---|
eudicotyledons | 68 |
rosids | 7 |
family name | count |
---|---|
Berberidaceae | 25 |
Ranunculaceae | 23 |
Papaveraceae | 18 |
Rutaceae | 7 |
Menispermaceae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL295124 |
CHEMBL1614110
(1)
CHEMBL1741321
(1)
|
1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL295124 |
CHEMBL1613842
(1)
|
4 / 2 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | CHEMBL295124 |
CHEMBL2169429
(1)
|
1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | CHEMBL295124 |
CHEMBL2169431
(1)
|
0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL295124 |
CHEMBL1676103
(1)
|
2 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL295124 |
CHEMBL1614361
(1)
|
3 / 2 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL295124 |
CHEMBL1741325
(1)
|
0 / 1 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL295124 |
CHEMBL1614458
(1)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL295124 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | CHEMBL295124 |
CHEMBL2169430
(1)
|
1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL295124 |
CHEMBL1741322
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL295124 |
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL295124 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (1) |
0 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL295124 |
CHEMBL1614421
(1)
|
4 / 3 |
O14746 | Telomerase reverse transcriptase | Enzyme | CHEMBL295124 |
CHEMBL1958529
(1)
|
5 / 5 |
O00255 | Menin | Unclassified protein | CHEMBL295124 |
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL295124 |
CHEMBL1614531
(1)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL295124 |
CHEMBL1613933
(1)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL295124 |
CHEMBL1613933
(1)
|
1 / 6 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D001599 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Berberine results in increased activity of AHR protein |
increases activity
|
protein |
16046213
|
D001599 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Berberine results in increased expression of BAX mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Berberine results in increased expression of BAX protein |
increases expression
|
protein |
16505103
20656010 |
D001599 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Berberine results in decreased expression of BCL2 mRNA |
decreases expression
|
mRNA |
20656010
|
D001599 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Berberine results in decreased expression of BCL2 protein |
decreases expression
|
protein |
16505103
20656010 |
D001599 | 598 |
BCL2L1
BCL-XL/S BCL2L BCLX BCLXL BCLXS Bcl-X PPP1R52 bcl-xL bcl-xS |
BCL2-like 1 | Berberine results in decreased expression of BCL2L1 protein |
decreases expression
|
protein |
16505103
|
D001599 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | Berberine binds to BIRC5 promoter |
affects binding
|
promoter |
17968851
|
D001599 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Berberine results in increased activity of CASP3 protein |
increases activity
|
protein |
20656010
|
D001599 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Berberine results in increased cleavage of and results in increased activity of CASP3 protein |
increases activity
/ increases cleavage |
protein |
16505103
|
D001599 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Berberine results in increased expression of CASP3 mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Berberine results in increased activity of CASP8 protein |
increases activity
|
protein |
20656010
|
D001599 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Berberine results in increased cleavage of CASP9 protein |
increases cleavage
|
protein |
16505103
|
D001599 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16391493
|
D001599 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16391493
|
D001599 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | Berberine results in decreased expression of CCND1 protein |
decreases expression
|
protein |
16505103
|
D001599 | 894 |
CCND2
KIAK0002 |
cyclin D2 | Berberine results in decreased expression of CCND2 protein |
decreases expression
|
protein |
16505103
|
D001599 | 898 |
CCNE1
CCNE |
cyclin E1 | Berberine results in decreased expression of CCNE1 protein |
decreases expression
|
protein |
16505103
|
D001599 | 1017 |
CDK2
p33(CDK2) |
cyclin-dependent kinase 2 (EC:2.7.11.22) | Berberine results in decreased expression of CDK2 protein |
decreases expression
|
protein |
16505103
|
D001599 | 1019 |
CDK4
CMM3 PSK-J3 |
cyclin-dependent kinase 4 (EC:2.7.11.22) | Berberine results in decreased expression of CDK4 protein |
decreases expression
|
protein |
16505103
|
D001599 | 1021 |
CDK6
PLSTIRE |
cyclin-dependent kinase 6 (EC:2.7.11.22) | Berberine results in decreased expression of CDK6 protein |
decreases expression
|
protein |
16505103
|
D001599 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Berberine results in increased expression of CDKN1A protein |
increases expression
|
protein |
16505103
|
D001599 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Berberine results in increased expression of CDKN1B protein |
increases expression
|
protein |
16505103
|
D001599 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Berberine affects the localization of CYCS protein |
affects localization
|
protein |
16505103
|
D001599 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Berberine results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
16046213
|
D001599 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Berberine results in increased expression of CYP1A1 mRNA |
increases expression
|
mRNA |
16046213
|
D001599 | 355 |
FAS
ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Fas cell surface death receptor | Berberine results in increased expression of FAS mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 355 |
FAS
ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6 |
Fas cell surface death receptor | Berberine results in increased expression of FAS protein |
increases expression
|
protein |
20656010
|
D001599 | 356 |
FASLG
ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 |
Fas ligand (TNF superfamily, member 6) | Berberine results in increased expression of FASLG mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 356 |
FASLG
ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 |
Fas ligand (TNF superfamily, member 6) | Berberine results in increased expression of FASLG protein |
increases expression
|
protein |
20656010
|
D001599 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Berberine inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
protein |
16391493
|
D001599 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Berberine inhibits the reaction [IL1B protein results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
protein |
16391493
|
D001599 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Berberine inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Berberine inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Berberine inhibits the reaction [IL1B protein results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16391493
|
D001599 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Berberine inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Berberine inhibits the reaction [TNF protein results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16391493
|
D001599 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Berberine inhibits the reaction [TNF protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | arsenic trioxide promotes the reaction [Berberine results in decreased activity of MMP2 protein] |
decreases activity
/ increases reaction |
protein |
18294404
|
D001599 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | Berberine promotes the reaction [arsenic trioxide results in decreased activity of MMP2 protein] |
decreases activity
/ increases reaction |
protein |
18294404
|
D001599 | 4313 |
MMP2
CLG4 CLG4A MMP-II MONA TBE-1 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | Berberine results in decreased activity of MMP2 protein |
decreases activity
|
protein |
18294404
|
D001599 | 5027 |
P2RX7
P2X7 |
purinergic receptor P2X, ligand-gated ion channel, 7 | Berberine affects the reaction [3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate results in increased activity of P2RX7 protein] |
affects reaction
/ increases activity |
protein |
21320518
|
D001599 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | Berberine results in increased cleavage of PARP1 protein |
increases cleavage
|
protein |
16505103
|
D001599 | 6476 |
SI
|
sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48) | Berberine results in decreased expression of SI mRNA |
decreases expression
|
mRNA |
20229011
|
D001599 | 6476 |
SI
|
sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48) | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Berberine results in decreased expression of SI mRNA] |
decreases expression
/ decreases reaction |
mRNA |
20229011
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA] |
decreases reaction
/ increases expression |
protein |
16391493
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine inhibits the reaction [TNF protein results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
protein |
16391493
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine inhibits the reaction [TNF protein results in increased secretion of CCL2 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine inhibits the reaction [TNF protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
16391493
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine results in increased expression of TNF mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Berberine results in increased secretion of TNF protein |
increases secretion
|
protein |
20656010
|
D001599 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Berberine results in increased expression of TP53 mRNA |
increases expression
|
mRNA |
20656010
|
D001599 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Berberine results in increased expression of TP53 protein |
increases expression
|
protein |
20656010
|
D001599 | 7185 |
TRAF1
EBI6 MGC:10353 |
TNF receptor-associated factor 1 | Berberine results in increased expression of TRAF1 protein |
increases expression
|
protein |
20656010
|
OMIM | preferred title | UniProt |
---|---|---|
#609135 | Aplastic anemia |
O14746
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 |
O14746
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 |
O14746
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 |
O14746
|
#178500 | Pulmonary fibrosis, idiopathic; ipf |
O14746
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00764 | Cri du chat syndrome |
O14746
(related)
|
H01132 | Aplastic anemia (AA) |
O14746
(related)
|
H01299 | Idiopathic pulmonary fibrosis |
O14746
(related)
|
H00022 | Bladder cancer |
O14746
(marker)
|
H00024 | Prostate cancer |
O14746
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000647 | D001599 | Amnesia |
therapeutic
|
9268086
|
|
D001862 | D001599 | Bone Resorption |
therapeutic
|
9881647
|
|
D002471 | D001599 | Cell Transformation, Neoplastic |
therapeutic
|
18951886
|
|
D003556 | D001599 | Cystitis |
therapeutic
|
11393582
|
|
D003920 | D001599 | Diabetes Mellitus |
therapeutic
|
22342832
|
|
D003921 | D001599 | Diabetes Mellitus, Experimental |
therapeutic
|
20229011
|
|
D003924 | D001599 | Diabetes Mellitus, Type 2 |
therapeutic
|
19080170
|
|
D004487 | D001599 | Edema |
therapeutic
|
11393582
|
|
D006470 | D001599 | Hemorrhage |
therapeutic
|
11393582
|
|
D006937 | D001599 | Hypercholesterolemia |
therapeutic
|
22342832
|
|
D006943 | D001599 | Hyperglycemia |
therapeutic
|
22342832
|
|
D006949 | D001599 | Hyperlipidemias |
therapeutic
|
20656010
|
|
D006973 | D001599 | Hypertension |
therapeutic
|
22342832
|
|
D007077 | D001599 | Ileal Diseases |
therapeutic
|
21963898
|
|
D007333 | D001599 | Insulin Resistance |
therapeutic
|
18563319
|
|
D007410 | D001599 | Intestinal Diseases |
therapeutic
|
20656010
21073932 |
|
D009369 | D001599 | Neoplasms |
therapeutic
|
12415430
|
|
D010190 | D001599 | Pancreatic Neoplasms |
therapeutic
|
21491092
|
|
D011471 | D001599 | Prostatic Neoplasms |
therapeutic
|
16505103
|